Seegene has participated 2011 American Association for Clinical Chemistry Annual Meeting 
(AACC) in Atlanta, the U.S. from July 26 till 28. 

Clinical laboratory professionals, physicians, research scientists, other individuals involved with clinical chemistry and diagnostics, immune, and lab automation related disciplines from approximately 100 countries worldwide have come for AACC. In addition to that, buyers and more than 2,000 companies participated in the exhibition.

Seegene represented a newly developed technology called TOCE; a new platform technology by melting curve analysis for Real-time PCR, and TOCE technology applied products such as RV16 and STI 7. TOCE tm has overcome issues with current melting curve analysis methods and it is designated not to be affected by sequence variation. Therefore, it guarantees consistent Tm values. Many participants visited our booth to get information about TOCE technology and showed their great interests to Seegene’s products.

Furthermore, Seegene’s proprietary DPO primer animation clip was proudly presented in AACC for the first time. It was produced to target newly joined distributors or end users, visitors who wish to do business with Seegene in order to show the excellence of Seegene’s specialized primer. The animation was made to emphasize and deliver the principle and characteristics of DPO primer and its applications efficiently in a short time.  

Our current distributor who have visited Seegene’s booth quoted “The DPO primer animation would be a great medium for promoting Seegene’s various simultaneous detection products”. “I can’t not wait until I introduce this animation to my customers after the exhibition” he continued.

Meanwhile, Seegene have already finished registering for AACC exhibition in 2012 and
AACC will be held in LA convention center, the United States. from July 17-19.